Insider Selling: Chemed (NYSE:CHE) Director Sells 1,347 Shares of Stock

Chemed Corporation (NYSE:CHE) Director Andrea Lindell sold 1,347 shares of the business’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Chemed Stock Performance

Shares of NYSE:CHE traded down $9.45 during midday trading on Wednesday, reaching $436.81. The company had a trading volume of 109,263 shares, compared to its average volume of 230,180. The company’s 50 day moving average price is $412.34 and its 200 day moving average price is $424.66. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The stock has a market cap of $5.80 billion, a P/E ratio of 23.80, a P/E/G ratio of 1.65 and a beta of 0.54. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $562.77.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the firm earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s payout ratio is 13.08%.

Institutional Investors Weigh In On Chemed

Several institutional investors have recently added to or reduced their stakes in the business. Commonwealth Equity Services LLC increased its position in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after buying an additional 22 shares during the period. Cim LLC increased its position in shares of Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after buying an additional 24 shares during the period. Smartleaf Asset Management LLC increased its position in shares of Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after buying an additional 25 shares during the period. Eukles Asset Management increased its position in shares of Chemed by 0.4% during the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock valued at $2,591,000 after buying an additional 25 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in shares of Chemed by 9.4% during the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock valued at $153,000 after buying an additional 35 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on CHE shares. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Royal Bank Of Canada upped their price objective on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Monday. Oppenheimer dropped their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.